NF-kappaB activation limits airway branching through inhibition of Sp1-mediated fibroblast growth factor-10 expression.
about
Cooperative roles for emmprin and LYVE-1 in the regulation of chemoresistance for primary effusion lymphoma.Enhanced NF-κB activity impairs vascular function through PARP-1-, SP-1-, and COX-2-dependent mechanisms in type 2 diabetes.Sustained hyperoxia-induced NF-κB activation improves survival and preserves lung development in neonatal mice.Perinatal factors in neonatal and pediatric lung diseasesPostnatal Infections and Immunology Affecting Chronic Lung Disease of Prematurity.Epithelial β1 integrin is required for lung branching morphogenesis and alveolarization.Respiratory syncytial virus induced type I IFN production by pDC is regulated by RSV-infected airway epithelial cells, RSV-exposed monocytes and virus specific antibodiesTargeting inflammation to prevent bronchopulmonary dysplasia: can new insights be translated into therapies?NF-κB signaling in fetal lung macrophages disrupts airway morphogenesis.A breath of fresh air on the mesenchyme: impact of impaired mesenchymal development on the pathogenesis of bronchopulmonary dysplasia.Aberrant signaling pathways of the lung mesenchyme and their contributions to the pathogenesis of bronchopulmonary dysplasiaLPS Down-Regulates Specificity Protein 1 Activity by Activating NF-κB Pathway in Endotoxemic Mice.Thrombin down-regulates tissue factor pathway inhibitor expression in a PI3K/nuclear factor-κB-dependent manner in human pleural mesothelial cells.Antenatal inflammation reduces expression of caveolin-1 and influences multiple signaling pathways in preterm fetal lungs.Activation of nuclear factor-kappa B accelerates vascular calcification by inhibiting ankylosis protein homolog expressionInnate immune activation in neonatal tracheal aspirates suggests endotoxin-driven inflammation.RAGE and tobacco smoke: insights into modeling chronic obstructive pulmonary disease.Nonmuscle myosin II regulation of lung epithelial morphology.LPS-induced chorioamnionitis and antenatal corticosteroids modulate Shh signaling in the ovine fetal lung.A Relationship between Epithelial Maturation, Bronchopulmonary Dysplasia, and Chronic Obstructive Pulmonary Disease.M2 macrophage polarisation is associated with alveolar formation during postnatal lung development.Protective effect of chorioamnionitis on the development of bronchopulmonary dysplasia triggered by postnatal systemic inflammation in neonatal rats.Interactions between NF-κB and SP3 connect inflammatory signaling with reduced FGF-10 expression.Epithelial-Derived Inflammation Disrupts Elastin Assembly and Alters Saccular Stage Lung DevelopmentRespiratory infections in preterm infants and subsequent asthma: a cohort study.Macrophages and CSF-1: implications for development and beyondIL-1β and Inflammasome Activity Link Inflammation to Abnormal Fetal Airway Development.Pathogenesis and treatment of bronchopulmonary dysplasia.Recent advances in late lung development and the pathogenesis of bronchopulmonary dysplasia.Tissue crosstalk in lung development.Conditional deletion of epithelial IKKβ impairs alveolar formation through apoptosis and decreased VEGF expression during early mouse lung morphogenesis.The innate immune response in fetal lung mesenchymal cells targets VEGFR2 expression and activity.Epithelial-mesenchymal co-culture model for studying alveolar morphogenesis.Therapeutic effects of fibroblast growth factor-10 on hyperoxia-induced bronchopulmonary dysplasia in neonatal mice.Alveolar NF-κB signaling regulates endotoxin-induced lung inflammation.IL-1β expression in the distal lung epithelium disrupts lung morphogenesis and epithelial cell differentiation in fetal mice.The effect of CSF-1 administration on lung maturation in a mouse model of neonatal hyperoxia exposure.Role of human TLR4 in respiratory syncytial virus-induced NF-κB activation, viral entry and replication.Systemic hydrogen sulfide administration partially restores normal alveolarization in an experimental animal model of bronchopulmonary dysplasia.Fgf10 deficiency is causative for lethality in a mouse model of bronchopulmonary dysplasia.
P2860
Q30418735-AB487514-3BBD-4738-A832-3C7915B01716Q30540016-60B6640E-E965-4E3A-87D1-2057315C6ECEQ33764746-D5F5FED5-A3EF-4CF0-B9CA-F27FCFFB8983Q33945932-DBF6A2FE-59EE-4431-A0E1-29A4629B4BB0Q34502529-481F9C88-A894-42A5-B9A1-3C8377EDF7BBQ34985774-5BF9E60E-0C39-4508-9DEB-C85AD239FC87Q35058641-10415F27-72AD-40A9-B3F8-A6E32F44691DQ35070866-061597EF-1635-4EE5-BAD3-524B354ABE1CQ35175565-324B49F4-25D7-4D78-80EB-4353353F31FFQ35545614-BD9D1751-AD9B-40DD-80F9-13CECD3EC5E5Q35667226-C943178A-F6E5-42DB-ACBB-9E5C7AE8D773Q35672036-6A0B796B-D786-4B26-99FA-9AAC54C45B4AQ35816399-C1CD2775-8347-4B09-BBED-CF341F1B0231Q35991319-37BA2FEE-0217-4996-B0BC-A28B8E88B980Q36035490-411BDDE8-CAEE-42A3-9418-579EB9CC4EC7Q36121600-37507D33-CDF0-4DC5-9B74-BFE62599FCFAQ36193793-A4C6B620-D240-4D84-A498-9B6F0C7CBBE6Q36357626-B014A8E2-0138-4A98-A147-4BAA1E88DD34Q36454401-A8F45D38-7F9E-405C-9E85-219EB6765018Q36520558-EA1EDDF8-3732-4561-898A-6D1D1EE23718Q36767465-1BB19174-5C23-4409-8F1B-55191BFA2656Q36793222-601C4D20-60C4-4269-88FA-A4B204576F7CQ36873716-48C8FE0C-8493-497A-96A5-181030DCA107Q37057138-A0FECEC7-6A00-455E-ADD0-F3447B9A5A76Q37275847-2774F53C-EBFC-4148-B83C-53E280469849Q37521345-FF8E0ABD-E040-4E19-9649-AA40986F50E9Q37649826-7F12F067-CBE7-47AB-B6F4-ECD7F9D5FBCCQ37865356-E81A95E2-60E9-400C-8DE9-4BF49B2FF8E9Q38161431-96818753-F63C-4631-B375-FC1B5BC3AF0FQ38197139-AFEC93CD-286C-4867-9CE8-576D1FA2E439Q38835068-5DEC8F6C-1EBD-40F7-B4B6-7B75294FD365Q38880928-BCA36619-DA5D-418F-A066-5CFC4D38F392Q39080842-B4150BCE-A3A1-4BC3-98D0-3427A6BC09CFQ40071409-AFE4579B-E81A-4B47-8628-89FB634D2D37Q41594929-A41BD3C6-F24A-499A-B547-B2BC0E4CB51EQ42241987-6E2BDF6E-0488-43ED-8C17-6C045ADB2326Q42911752-088AD211-A56B-4A6E-8CAE-892F8C50EEA7Q45358034-8EF68711-DF41-4551-8B37-D3CA4489CF0BQ45743135-F306A712-24AF-4AAE-AD8B-D8A10F0A8792Q45940168-9D2932D4-B397-4603-AFDA-EE8E48D01606
P2860
NF-kappaB activation limits airway branching through inhibition of Sp1-mediated fibroblast growth factor-10 expression.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
NF-kappaB activation limits ai ...... t growth factor-10 expression.
@ast
NF-kappaB activation limits ai ...... t growth factor-10 expression.
@en
type
label
NF-kappaB activation limits ai ...... t growth factor-10 expression.
@ast
NF-kappaB activation limits ai ...... t growth factor-10 expression.
@en
prefLabel
NF-kappaB activation limits ai ...... t growth factor-10 expression.
@ast
NF-kappaB activation limits ai ...... t growth factor-10 expression.
@en
P2093
P2860
P356
P1476
NF-kappaB activation limits ai ...... t growth factor-10 expression.
@en
P2093
Billy J Carver
Erin J Plosa
J Davin Miller
Jin-Hua Liu
John T Benjamin
Lawrence S Prince
Riet van der Meer
Timothy S Blackwell
Yasutoshi Yamamoto
P2860
P304
P356
10.4049/JIMMUNOL.1001857
P407
P577
2010-09-22T00:00:00Z